RT @dhurvas2007: New publication update! #collaboration #JAK2 #JAK #Kinases #drugresistance #insilico #Oncology #mutations @HariGorantla2 @…
97 followers
6,544 followers
New Research: Type II mode of JAK2 inhibition and destabilization are potential therapeutic approaches against the ruxolitinib resistance driven myeloproliferative neoplasms https://t.co/hH7cLyzKXZ #FrontiersIn #Oncology
253 followers
New publication update! #collaboration #JAK2 #JAK #Kinases #drugresistance #insilico #Oncology #mutations @HariGorantla2 @IOCBPrague @TheBouraLab @FrontiersIn Spl thanks to Dr. Chandrabose Selvaraj @selnikraj Gorantla et al., 2024. Frontiers in Oncology